BamSEC and AlphaSense Join Forces
Learn More

Prelude Therapeutics Incorporated – Indentures

NASDAQ: PRLD    
Share price (11/13/26): $3.45    
Market cap (11/13/26): $275 million

Indentures Filter

EX-4.1
from 8-K 12 pages Prelude Therapeutics Incorporated Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from S-3 36 pages Prelude Therapeutics Incorporated and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.4
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.5
from 10-K 10 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 19 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 13 pages Prelude Therapeutics Incorporated Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 11 pages Prelude Therapeutics Incorporated Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 35 pages Prelude Therapeutics Incorporated and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.4
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.4
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-1 17 pages Registration Rights Agreement
12/34/56
EX-4.3
from DRS 17 pages Pursuant to 17 C.F.R. Section 200.83
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 51 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS/A 51 pages Amended and Restated Investors’ Rights Agreement
12/34/56